447 related articles for article (PubMed ID: 25069991)
1. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.
Harman SM; Black DM; Naftolin F; Brinton EA; Budoff MJ; Cedars MI; Hopkins PN; Lobo RA; Manson JE; Merriam GR; Miller VM; Neal-Perry G; Santoro N; Taylor HS; Vittinghoff E; Yan M; Hodis HN
Ann Intern Med; 2014 Aug; 161(4):249-60. PubMed ID: 25069991
[TBL] [Abstract][Full Text] [Related]
2. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial.
El Khoudary SR; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman M; Naftolin F; Hodis HN; Brinton EA; Miller VM; Taylor HS; Budoff MJ
Menopause; 2020 Mar; 27(3):255-262. PubMed ID: 32015261
[TBL] [Abstract][Full Text] [Related]
3. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
[TBL] [Abstract][Full Text] [Related]
4. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
Hodis HN; Mack WJ; Henderson VW; Shoupe D; Budoff MJ; Hwang-Levine J; Li Y; Feng M; Dustin L; Kono N; Stanczyk FZ; Selzer RH; Azen SP;
N Engl J Med; 2016 Mar; 374(13):1221-31. PubMed ID: 27028912
[TBL] [Abstract][Full Text] [Related]
5. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
[TBL] [Abstract][Full Text] [Related]
6. Lessons from KEEPS: the Kronos Early Estrogen Prevention Study.
Miller VM; Taylor HS; Naftolin F; Manson JE; Gleason CE; Brinton EA; Kling JM; Cedars MI; Dowling NM; Kantarci K; Harman SM
Climacteric; 2021 Apr; 24(2):139-145. PubMed ID: 32880220
[TBL] [Abstract][Full Text] [Related]
7. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.
Hodis HN; Mack WJ; Shoupe D; Azen SP; Stanczyk FZ; Hwang-Levine J; Budoff MJ; Henderson VW
Menopause; 2015 Apr; 22(4):391-401. PubMed ID: 25380275
[TBL] [Abstract][Full Text] [Related]
8. Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS).
Wolff EF; He Y; Black DM; Brinton EA; Budoff MJ; Cedars MI; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Pal L; Santoro N; Zhang H; Harman SM; Taylor HS
Fertil Steril; 2013 Apr; 99(5):1385-91. PubMed ID: 23312232
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
[TBL] [Abstract][Full Text] [Related]
10. Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial.
El Khoudary SR; Zhao Q; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman SM; Cedars MI; Hopkins PN; Kearns AE; Miller VM; Taylor HS; Budoff MJ
J Am Heart Assoc; 2019 Aug; 8(15):e012763. PubMed ID: 31652073
[TBL] [Abstract][Full Text] [Related]
11. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of atherosclerosis in postmenopausal women: alteration of atherosclerosis-associated factors and vascular atherosclerosis by oral and transdermal estrogen replacement].
Sumino H; Murakami M
Rinsho Byori; 2013 Mar; 61(3):256-62. PubMed ID: 23785796
[TBL] [Abstract][Full Text] [Related]
13. Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: follow-up from the Kronos Early Estrogen Prevention Study.
Miller VM; Hodis HN; Lahr BD; Bailey KR; Jayachandran M
Menopause; 2019 Jan; 26(1):24-31. PubMed ID: 30020254
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
Kalyan S; Hitchcock CL; Sirrs S; Pudek M; Prior JC
Pharmacotherapy; 2010 May; 30(5):442-52. PubMed ID: 20411996
[TBL] [Abstract][Full Text] [Related]
15. Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy.
Cintron D; Beckman JP; Bailey KR; Lahr BD; Jayachandran M; Miller VM
Maturitas; 2017 May; 99():59-65. PubMed ID: 28364870
[TBL] [Abstract][Full Text] [Related]
16. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
[TBL] [Abstract][Full Text] [Related]
17. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial.
Casanova G; Spritzer PM
Lipids Health Dis; 2012 Oct; 11():133. PubMed ID: 23046709
[TBL] [Abstract][Full Text] [Related]
18. Effect of Half-dose and Standard-dose Conjugated Equine Estrogens Combined with Natural Progesterone or Dydrogesterone on Components of Metabolic Syndrome in Healthy Postmenopausal Women: A Randomized Controlled Trial.
Xue W; Deng Y; Wang YF; Sun AJ
Chin Med J (Engl); 2016 Dec; 129(23):2773-2779. PubMed ID: 27900987
[TBL] [Abstract][Full Text] [Related]
19. Differential Effect of Plasma Estradiol on Subclinical Atherosclerosis Progression in Early vs Late Postmenopause.
Sriprasert I; Hodis HN; Karim R; Stanczyk FZ; Shoupe D; Henderson VW; Mack WJ
J Clin Endocrinol Metab; 2019 Feb; 104(2):293-300. PubMed ID: 30272234
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
